"Old" Antibiotics Face More Generic Pressure After FDA Denies 30-Month Stays
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva's brief at-risk launch of the acne product Solodyn followed by a settlement with Medicis may serve as template.
You may also be interested in...
Dermatology Space Waits For Skinny On Stiefel Buyout
Pure dermatology plays abound, but few are big enough to take on privately held Stiefel; where the company will find a fit is anybody’s guess.
Dermatology Space Waits For Skinny On Stiefel Buyout
Pure dermatology plays abound, but few are big enough to take on privately held Stiefel; where the company will find a fit is anybody’s guess.
“Old” Antibiotics May Get Exclusivity Under New Law; 10 Drugs Could Benefit
Drug manufacturers could get marketing exclusivity for a handful of old antibiotics under legislation passed by the House and Senate last month